[Levitra (oral dispersible tablet)--an innovative drug for the treatment of patients with erectile dysfunction]

Urologiia. 2013 Mar-Apr:(2):106-8, 110-1.
[Article in Russian]

Abstract

The arsenal of professionals providing assistance to men with erectile dysfunction includes a new, mouth dissolving dosage form of the vardenafil--levitra ODT. This form is effective, safe, and has a higher bioavailability as compared to vardenafil in the form of coated tablets. POTENT I and POTENT II studies revealed that levitra ODT equally successfully corrects erectile dysfunction in men younger and older than 65 years regardless of concomitant diseases and metabolic disorders: hypertension, diabetes, dyslipidemia. In addition, it was found that this drug helped to successfully carry out sexual intercourse in the first 15 minutes after dosing in 62.5% of patients. This allows to widely recommend levitra ODT for the treatment of erectile dysfunction in young men and older men.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Administration, Oral
  • Aged
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / etiology
  • Erectile Dysfunction / physiopathology
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Metabolic Diseases / complications
  • Metabolic Diseases / drug therapy
  • Metabolic Diseases / physiopathology
  • Middle Aged
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Piperazines / therapeutic use*
  • Sulfones / therapeutic use
  • Triazines / therapeutic use
  • Vardenafil Dihydrochloride

Substances

  • Imidazoles
  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Sulfones
  • Triazines
  • Vardenafil Dihydrochloride